Abstract
Crizotinib (CZT) is a potent and selective tyrosine kinase inhibitor used for treatment of non-small cell lung cancer (NSCLC). The development of high......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
